Molecular investigations in canine gliomas have revealed genetic alterations in RTK/RAS/PI3K, RB, p53, and other genes encoding for cell cycle regulators and growth factors, suggesting canine and human glioma share molecular abnormalities involving same major cell signaling pathways [7,9,10,19]. This evidence concerns the gene RB1 and central nervous system cancer.